Search Results - "Tordjman, Karen Michele"
-
1
Indeterminate nodules by the Bethesda system for reporting thyroid cytopathology in Israel: Frequency, and risk of malignancy after reclassification of follicular thyroid neoplasm with papillary-like features
Published in European journal of surgical oncology (01-07-2019)“…We aimed to determine the frequency and risk of malignancy (ROM) for indeterminate thyroid nodules, categories III (B3) and IV (B4) of the Bethesda System for…”
Get full text
Journal Article -
2
SAT406 Evaluation Of The Emotional And Cognitive Effects Of Hormone Therapy In Transgender Men And Women
Published in Journal of the Endocrine Society (05-10-2023)“…Abstract Disclosure: I. Yaish: None. G. Keltch: None. Y. Greenman: None. K.M. Tordjman: None. Background:- Sex hormones have far-reaching effects on the brain,…”
Get full text
Journal Article -
3
FRI542 Long-term Metabolic Outcomes In Graves’ Disease: Is There A Difference Between Oral Anti-thyroid Medications And Radioactive Iodine Treatment?
Published in Journal of the Endocrine Society (05-10-2023)“…Abstract Disclosure: E. Shemesh: None. T. Kolitz: None. A. Nathan: None. K.M. Tordjman: None. Y. Greenman: None. E. Izkhakov: None. Introduction: The treatment…”
Get full text
Journal Article -
4
SAT394 Over-representation Of Adoptees Among Transgender Subjects Seeking Gender-Affirming-Hormonal-Therapy (GAHT) In A Large Tertiary Medical Center
Published in Journal of the Endocrine Society (05-10-2023)“…Abstract Disclosure: I. Yaish: None. G. Keltch: None. Y. Greenman: None. T. Kolitz: None. K.M. Tordjman: None. Background: The etiology of transgenderism is…”
Get full text
Journal Article -
5
SAT409 Sublingual Estradiol Only, Compared To Combined Oral Estradiol And Cyproterone Acetate,Offers No Apparent Advantage For Gender Affirming Hormone Therapy (GHAT), In Treatment Naïve Transwomen: Results Of A Prospective Pilot Study
Published in Journal of the Endocrine Society (05-10-2023)“…Abstract Disclosure: I. Yaish: None. G. Gindis: None. Y. Greenman: None. G. Shefer: None. A. Buch: None. M. Arbiv: None. Y. Moshe: None. Y. Sofer: None. K.M…”
Get full text
Journal Article -
6
7122 Obesity is associated with lower basal state cortisol, and diminished cortisol response to the low dose 1ug ACTH: time to depart from the obesity/pseudo-Cushing myth
Published in Journal of the Endocrine Society (05-10-2024)“…Abstract Disclosure: Y. Sofer: None. E. Osher: None. Y. Greenman: None. K.M. Tordjman: None. G. Shenkerman: None. M. Yaron: None. Y. Marcus-Perlman: None. Y…”
Get full text
Journal Article -
7
Intravenous Thyroxine Administration in Hospitalized Patients, a Common but Unreported Practice: a Single Institution Recent Experience
Published in Journal of the Endocrine Society (03-05-2021)“…Abstract Background: Intravenous levothyroxine (IVT4) is FDA-approved for the treatment of myxedema coma (ME). ATA guidelines also acknowledge other rare…”
Get full text
Journal Article -
8
A Cross Sectional Analysis of the Prevalence of Co-Morbidities in Older Transgender Individuals Receiving Hormone Affirming Therapy in Comparison With the General Population
Published in Journal of the Endocrine Society (03-05-2021)“…Abstract Background: Transgender individuals feel an incongruity between the assigned gender at birth and their gender identity. Because the prevalence of…”
Get full text
Journal Article -
9
SAT-180 Adrenocortical Carcinoma - A Tertiary Center’s Recent 5-Year Experience
Published in Journal of the Endocrine Society (08-05-2020)“…Abstract BACKGROUND: Adrenocortical carcinoma (ACC) is a rare endocrine malignancy with poor prognosis. The aim of this study was to characterize patients…”
Get full text
Journal Article -
10
MON-194 Phaeochromocytoma-Paraganglioma (PPGL): Post-Operative Hypotension Is a Vanishing Phenomenon
Published in Journal of the Endocrine Society (08-05-2020)“…Abstract Background: Treatment of hemodynamic instability in patients with PPGL in the intra-and postoperative periods is challenging. Persistent postoperative…”
Get full text
Journal Article